Pricing

Log In

Michel Bouvier

Chairman, Scientific Advisory Board at Domain Therapeutics SA

Michel Bouvier

Michel Bouvier

Chairman, Scientific Advisory Board at Domain Therapeutics SA

Overview

RelSci Relationships

44

Number of Boards

2

Relationships

View Relationship Details

RelSci Relationships are individuals Michel Bouvier likely has professional access to. A relationship does not necessarily indicate a personal connection.

Barry Byrne

Founder at Applied Genetic Technologies Corp.

Relationship likelihood: Strong

Gregory A. Petsko

Professor Emeritus, Biochemistry at Brandeis University

Relationship likelihood: Strong

Stuart Kornfeld

Professor, Department of Biochemistry & Molecular Biophysics at Washington University in St.Louis - School of Medicine

Relationship likelihood: Strong

Pascal Neuville

Chief Executive Officer, Director & Chief Scientific Officer at Domain Therapeutics SA

Relationship likelihood: Strong

John F. Crowley

Chief Executive Officer at Amicus Therapeutics, Inc.

Relationship likelihood: Strong

Pierre Potier

Founder at Domain Therapeutics SA

Relationship likelihood: Average

Yves Dunant

Founder at Domain Therapeutics SA

Relationship likelihood: Average

Maurice Israel

Founder at Domain Therapeutics SA

Relationship likelihood: Average

Youssef L. Bennani

Vice President-Research & Development at Vertex Pharmaceuticals

Relationship likelihood: Average

Sébastien Groyer

Partner at Seventure Partners SA

Relationship likelihood: Average

Subscribe to RelSci Professional to see 44 more Relationships

In The News

ENP Newswire

February 28, 2018

-Domain Therapeutics grants Bristol-Myers Squibb non-exclusive license for G protein-coupled receptor bioSens-All technology

PR Newswire

June 15, 2015

New company will benefit patients undergoing transplants for leukemias

peHUB

April 8, 2015

AmorChem invests in cancer immunotherapy R&D program

PR Newswire

November 10, 2014

Encycle Therapeutics developing lead molecule to tackle inflammatory bowel disease

FierceBiotech

September 26, 2014

GSK taps Royal Bank of Scotland chair Philip Hampton to lead its own board

Subscribe now to see full news coverage

Paths to Michel Bouvier

Potential Connections via
Relationship Science

You

Michel Bouvier

Chairman, Scientific Advisory Board at Domain Therapeutics SA

Boards & Committees

Chairman, Scientific Advisory Board

2014 - Current

Domain Therapeutics SA

Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm’s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Israël, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in October 2001 and is headquartered in Illkirch-Graffenstaden, France.

Member, Scientific Advisory Board

Tenure Unconfirmed

Amicus Therapeutics, Inc.

Amicus Therapeutics, Inc. is a biotechnology company, which is engaged in the discovery, development and commercialization of novel treatments for patients living with rare and orphan diseases. Its product include migalastat HCl, which is a small molecule that can be used as a monotherapy and in combination with enzyme replacement therapy for fabry disease. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ.

Subscribe now to see corporate board memberships for over 7 million people

Subscribe now to see non-profit board memberships for over 7 million people

Subscribe now to see government board memberships for over 7 million people

Creating a news feed is your most valuable research tool. RelSci sends you actionable updates so you can keep tabs on the people and organizations you care about most.

Browse in-depth profiles on 9 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.